骨髓性恶性瘤中的克隆进化和层次结构
Koichi Takahashi1, Tomoyuki Tanaka2
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Trends in cancer
|June 11, 2023
概括
遗传和表观遗传的变化驱动了像AML,MDS和MPN这样的髓状瘤. 克隆进化研究和单细胞技术揭示了对其发展和新治疗策略的见解.
科学领域:
- 血液学 血液学 血液学
- 癌症基因组学 癌症基因组学
- 干细胞生物学 干细胞生物学
背景情况:
- 骨髓性恶性瘤,包括急性骨髓性白血病 (AML),骨髓性形综合征 (MDS) 和骨髓增殖性瘤 (MPN),源于血液造血干细胞和原始细胞 (HSPC) 中累积的遗传和表观遗传变化.
- 这些改变塑造了髓状细胞癌的基因组景观的确切机制尚未完全理解.
- 尽管与其他癌症相比,基因组驱动因素的数量相对有限,但进化途径仍然复杂.
研究的目的:
- 审查当前对骨髓性恶性瘤中克隆进化的理解.
- 探索最近的进展如何阐明这些疾病的发育过程.
- 讨论对新型诊断和治疗策略的影响.
主要方法:
- 关于克隆性血液形成的最新文献的综述.
- 整合了来自尖端单细胞技术的发现.
- 对HSPCs遗传和表观遗传变化的分析.
主要成果:
- 克隆性血液形成研究为骨髓性恶性瘤的起源提供了新的见解.
- 单细胞技术使我们能够更深入地了解细胞异质性和进化.
- 这项研究强调了疾病发展过程中基因组变化的动态性质.
结论:
- 了解克隆进化对于破译骨髓性恶性瘤的发病过程至关重要.
- 先进的技术是解开这些血液学疾病复杂性的关键.
- 这些知识为开发创新的诊断工具和向治疗铺平了道路.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
T Cell Activation and Clonal Selection
837
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
837
Cells of the Adaptive Immune Response
1.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.1K
Disorders of Leukocytes
988
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
988
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


